Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Sep 15  •  03:51PM ET
6.97
Dollar change
+0.03
Percentage change
0.43
%
IndexRUT P/E32.31 EPS (ttm)0.22 Insider Own21.29% Shs Outstand147.92M Perf Week-2.79%
Market Cap1.03B Forward P/E21.78 EPS next Y0.32 Insider Trans0.63% Shs Float116.46M Perf Month-2.52%
Enterprise Value930.83M PEG2.56 EPS next Q0.06 Inst Own51.53% Short Float4.27% Perf Quarter15.39%
Income32.17M P/S2.83 EPS this Y-4.29% Inst Trans3.36% Short Ratio6.69 Perf Half Y-12.00%
Sales363.77M P/B4.76 EPS next Y19.40% ROA12.26% Short Interest4.98M Perf YTD-27.55%
Book/sh1.46 P/C8.68 EPS next 5Y12.62% ROE16.62% 52W High10.14 -31.27% Perf Year12.60%
Cash/sh0.80 P/FCF17.71 EPS past 3/5Y- - ROIC13.76% 52W Low5.47 27.42% Perf 3Y103.79%
Dividend Est.- EV/EBITDA18.21 Sales past 3/5Y10.49% 3.12% Gross Margin81.29% Volatility2.81% 2.58% Perf 5Y7.23%
Dividend TTM- EV/Sales2.56 EPS Y/Y TTM-67.67% Oper. Margin11.88% ATR (14)0.22 Perf 10Y-29.03%
Dividend Ex-Date- Quick Ratio3.90 Sales Y/Y TTM6.85% Profit Margin8.84% RSI (14)47.19 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio4.39 EPS Q/Q-45.61% SMA20-2.06% Beta1.74 Target Price12.20
Payout0.00% Debt/Eq0.09 Sales Q/Q13.07% SMA50-0.08% Rel Volume0.37 Prev Close6.94
Employees837 LT Debt/Eq0.08 EarningsJul 30 AMC SMA200-8.04% Avg Volume743.60K Price6.97
IPOAug 22, 2007 Option/ShortYes / Yes EPS/Sales Surpr.11.11% 8.82% Trades Volume271,085 Change0.43%
Date Action Analyst Rating Change Price Target Change
Jul-02-24Initiated Cantor Fitzgerald Overweight $11
Mar-07-24Initiated Lake Street Buy $12
Oct-27-23Initiated Craig Hallum Buy $12
Oct-13-22Initiated Mizuho Buy $7
Jul-26-21Initiated Northland Capital Outperform $23
Mar-19-21Initiated H.C. Wainwright Buy $20
Sep-03-25 08:00AM
Aug-29-25 05:11AM
Aug-27-25 08:00AM
Jul-31-25 03:32AM
Jul-30-25 05:40PM
04:50PM Loading…
04:50PM
04:01PM
08:00AM
Jul-29-25 09:50AM
Jul-16-25 09:15AM
08:00AM
Jul-15-25 09:15AM
Jul-14-25 05:22PM
Jul-09-25 09:36AM
May-27-25 08:00AM
06:00AM Loading…
May-14-25 06:00AM
May-06-25 08:00AM
May-05-25 08:30AM
May-01-25 11:03AM
03:18AM
Apr-30-25 09:52PM
05:15PM
04:19PM
04:01PM
Apr-16-25 08:00AM
Apr-10-25 04:01PM
Mar-31-25 05:45PM
Mar-20-25 01:58AM
Feb-27-25 08:22AM
08:00AM
02:22AM Loading…
02:22AM
Feb-26-25 05:55PM
05:04PM
04:01PM
Feb-25-25 10:37AM
Feb-05-25 08:00AM
Dec-17-24 09:00AM
Dec-04-24 08:00AM
Nov-20-24 09:55AM
Nov-14-24 09:15AM
Nov-04-24 09:55AM
08:00AM
Oct-31-24 05:00AM
Oct-30-24 05:25PM
04:26PM
04:01PM
Oct-14-24 08:00AM
Oct-09-24 03:36PM
Oct-08-24 04:01PM
Oct-01-24 04:01PM
Sep-11-24 01:03PM
Sep-04-24 04:23PM
Aug-27-24 08:00AM
Aug-26-24 09:30AM
Jul-31-24 04:22PM
04:02PM
04:01PM
Jul-22-24 08:10AM
Jul-17-24 08:00AM
08:00AM
Jul-01-24 02:18PM
Jun-26-24 04:01PM
May-20-24 06:00AM
May-15-24 08:00AM
May-02-24 04:10PM
May-01-24 09:33AM
03:30AM
Apr-30-24 08:55PM
04:13PM
04:01PM
Apr-16-24 08:00AM
Apr-01-24 04:37PM
Mar-27-24 08:00AM
Mar-20-24 07:00AM
Mar-13-24 08:00AM
Mar-04-24 08:00AM
Feb-29-24 10:49AM
Feb-28-24 04:55PM
04:41PM
04:01PM
Feb-21-24 11:51PM
Feb-20-24 08:00AM
Feb-13-24 12:58PM
Feb-12-24 08:00AM
Jan-22-24 08:00AM
Jan-17-24 10:25AM
Dec-29-23 05:12PM
05:00PM
Dec-28-23 08:00AM
Nov-13-23 08:00AM
Nov-02-23 08:00AM
Oct-31-23 09:09AM
07:28AM
06:50AM
Oct-30-23 06:03PM
04:50PM
04:01PM
Oct-27-23 10:01AM
Oct-16-23 08:00AM
Sep-26-23 08:00AM
MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Capper Joseph HChief Executive OfficerMay 02 '25Buy6.34200,0001,268,000529,530May 05 10:06 AM
Maersk-Moller KimberlyChief Commercial OfficerMar 17 '25Sale8.041,75914,142309,077Mar 20 06:09 AM
Hulse William Frank IVGeneral Counsel and CAOMar 13 '25Sale7.8954,596430,762440,178Mar 14 05:58 PM
Maersk-Moller KimberlyChief Commercial OfficerMar 13 '25Sale7.894,10632,396310,836Mar 14 05:56 PM
Hulse William Frank IVGeneral Counsel and CAOMar 10 '25Sale7.8081,446635,279494,774Mar 12 07:56 PM
Hulse William Frank IVOfficerMar 10 '25Proposed Sale7.9481,446646,681Mar 10 01:40 PM
Maersk-Moller KimberlyChief Commercial OfficerFeb 28 '25Sale8.402,11117,743265,271Mar 05 07:13 PM
Whitlow Ricci SChief Operating OfficerFeb 13 '25Sale8.2861,420508,558403,019Feb 18 05:36 PM
GARDNER PHYLLISFormer DirectorOct 10 '24Proposed Sale5.5230,000165,637Oct 10 04:08 PM